@tinsilver0
Active 6 days, 17 hours ago
No patient exhibited PD-L1 expression. Atezolizumab plus carboplatin and etoposide therapy was effective in SCLC patients with sensitive and refractory relapse and might be a second-line treatment option for SCLC patients previously treated with platinum-based chemotherapy.Relatively high-latitude waters are supposed as a refuge for corals under […] View